Extended thromboprophylaxis for hip or knee arthroplasty. Does the administration route and dosage regimen affect adherence? A cohort study
Purpose: Prevention of thromboembolic disease requires patients’ adherence to the extended thromboprophylaxis scheme. Oral anticoagulants are expected to improve adherence as a result of their route of administration; however, this assumption is yet to be confirmed. The purpose of this study was to...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2020
- Institución:
- Universidad del Rosario
- Repositorio:
- Repositorio EdocUR - U. Rosario
- Idioma:
- eng
- OAI Identifier:
- oai:repository.urosario.edu.co:10336/22169
- Acceso en línea:
- https://doi.org/10.1007/s00264-019-04454-3
https://repository.urosario.edu.co/handle/10336/22169
- Palabra clave:
- Apixaban
Enoxaparin
Rivaroxaban
Adolescent
Adult
Aged
Article
Body mass
Cohort analysis
Controlled study
Drug administration route
Drug cost
Drug dose regimen
Drug withdrawal
Epistaxis
Female
Follow up
Health status
Hip arthroplasty
Hip fracture
Human
Knee arthroplasty
Major clinical study
Male
Medication compliance
Osteoarthritis
Patient compliance
Practice guideline
Prescription
Priority journal
Prospective study
Thrombosis prevention
Venous thromboembolism
Arthroplasty
Hip
Prevention and control
Replacement
Venous thromboembolism
- Rights
- License
- Abierto (Texto Completo)